News
Hims & Hers copies Novo Nordisk's new Wegovy pill
Competition has already arrived for Novo Nordisk's Wegovy pill, as telehealth company Hims & Hers launches a compounded version.
News
Amgen baulks at FDA request to withdraw Tavneos
Amgen confirmed on its fourth-quarter results call that it has resisted a request to pull Tavneos for ANCA-associated vasculitis from the US market.
News
Abbott's wireless heart failure sensor cleared for NHS use
A wireless sensor the size of a paperclip, Abbott's CardioMEMS HF, can now be used routinely by the NHS to monitor patients with heart failure.
Market Access
Biotech leaders: ‘They're shoving this industry into the arm...
At the Biotech Showcase during JPM Week, biotech leaders expressed frustration at the US's lack of concern about Chinese biotech progress.
News
Fears US drug pricing deal will weigh heavy on the NHS
The UK confirms that the cost of the drug pricing deal with the US, initially around £1bn over three years, will be borne by the health department.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
